RecruitingNot ApplicableNCT06801171

A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders

Randomized Clinical Trial Testing a Mixed Intervention to Improve Resilience in People Aged Over 60 Years With Neurocognitive Disorders.

Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment

90 participants

Start Date

Apr 30, 2025

Study Type

INTERVENTIONAL

Conditions

Cognitive Disorder

Summary

The study aims to test a program combining cognitive behavioral therapy techniques, positive psychology techniques, mindfulness meditation and yoga, in order to improve resilience in patient with minor cognitive disorder. This intervention will be compared to a control group, but also with a group testing another intervention (an intervention that does not improve resilience in the elderly, namely a "cognitive stimulation" intervention) in order to ensure that the effect potentially obtained is not due to the simple management of the participant. The duration of the intervention will be 3 months, with an evaluation directly before and after the intervention. In addition, in order to best evaluate the effectiveness of the interventions over time, two follow-up measurements will be proposed: a measurement one month after the intervention, then a final one three months after the intervention.

Eligibility

Min Age: 60 Years

Inclusion Criteria6

Man or Woman aged > 60 years
Have a minor neurocognitive disorder according to the criteria of the DSM 5
Score of 145 or less on the Wagnild and Young Resilience Scale (RS) (Wagnild, 2009).
Subject able to read and write French;
Subject beneficiaries of a social security scheme;
Ability to understand and sign free and informed consent.

Exclusion Criteria6

Subject already practicing meditation and/or yoga and/or Tai Chi
Subject currently undergoing psychological therapy (whatever the approach)
Subject with a major hearing, visual or motor disability likely to interfere with the proposed interventions or the performance of assessments;
Presence and/or recent history (within the last 5 years prior to inclusion in the study) of major psychiatric disorders (e.g., schizophrenia, severe depression, addiction, bipolar disorders, psychotic disorders, risk of dissociation, panic attack, generalized anxiety disorder, etc.)
If taking psychotropic treatment, the dose must have been stable for 4 weeks
Vulnerable persons are defined in Articles L1121-5 to -8

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcognitive stimulation

12 sessions (one per week for 12 weeks) in group of cognitive stimulation

OTHERmixed intervention

12 sessions (one per week for 12 weeks) in group of mixte stimulation (yoga, cognitive behavioral therapy, mindfullness meditation, positive psychology)